Finland· FI-REL-REL3783

Norvir

A ritonavir product containing ritonavir, registered in Finland by Abbott Laboratories Ltd.. The same ATC class is registered in 16 of our 19 countries.

ATC J05AE03

Checked against Fimea (Finland) on

Informational only — not a medical device.

SOURCE REGISTER · FIFimea (Finland)normalisedNorvirATCJ05AE03REGISTER NO.FI-REL-REL3783PACKS LISTED0CHECKEDSeptember 27, 2026

Where it is registered

Ritonavir is registered in 16 of 19 countries.

Countries holding a registration under ATC J05AE03 (ritonavir), each read from that country’s own register.

  • This record: Finland, from Fimea (Finland)
  • 9 of them publish a price we can compare per daily dose

Ritonavir · ATC J05AE03

16 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of ritonavir costs, country by country.

Normalised to the WHO defined daily dose (1.2 g), the median price runs from $4.15 in France to $20.09 in Switzerland — a ×4.8 gap.

  • 2 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Ritonavir · price per daily dose (1.2 g)

USD · FX 28 Sept 2026

  • CH Switzerland$20.09
  • FR France$4.15
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Fimea (Finland)
Active substance
Ritonavir
Manufacturer
Abbott Laboratories Ltd.
Country
Finland (FI)
ATC code
J05AE03
ATC class
Ritonavir
Defined daily dose
1.2 g, O
Reimbursed
Not published by this register
Source register
Fimea (Finland)
Last checked
September 27, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

515 interactions on record for ritonavir.

Graded by severity as the source publishes them — 149 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Ritonavir · interactions on record

515 records

  • 149 severe
  • 238 moderate
  • 19 minor
  • 66 info

Most severe, free to view

  • CisaprideA03FA02severe
  • NaloxegolA06AH03severe
  • LoperamideA07DA03severe
  • EluxadolineA07DA06severe

43 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Ritonavir in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All ritonavir products

Authorised across Europe · EMA

The same active substance is authorised in 18 EEA countries. Names it is sold under:

  • Austria · Ritonavir Accord
  • Belgium · Ritonavir Accord
  • Cyprus · Ritonavir Accord
  • Germany · Ritonavir Accord, Ritonavir Hexal
  • Denmark · Ritonavir Accord
  • Estonia · Ritonavir Auxilia
  • Spain · Ritonavir Accord
  • France · Ritonavir Arrow
  • United Kingdom (Northern Ireland) · Norvir, Ritonavir Accord Healthcare
  • Hungary · Ritonavir Accord
  • Iceland · Norvir, Ritonavir Viatris
  • Italy · Ritonavir Sandoz
  • Liechtenstein · Norvir, Ritonavir Viatris
  • Netherlands · Ritonavir Accord, Ritonavir Sandoz
  • Norway · Norvir, Ritonavir Viatris
  • Poland · Ritonavir Accord, Ritonavir Aurovitas
  • Portugal · Ritonavir Farmoz, Ritonavir Generis
  • Sweden · Ritonavir Accord

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/b573ac88-7134-4468-b451-7e0d35d72174
GET /v1/drugs/b573ac88-7134-4468-b451-7e0d35d72174?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "ddd": "1.2",
  "form": "kapseli",
  "route": null,
  "ddd_unit": "g",
  "strength": "100 mg",
  "atc_label": "ritonaviiri",
  "ma_number": null,
  "auth_status": "Myyntilupa peruuntunut",
  "eu_ma_number": "EU/1/96/016/002",
  "fimea_rel_id": "REL3783",
  "authorised_at": "1996-08-26"
}

See everything about ritonavir.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.